Pileje   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Rochefort France (1987)

Organization Overview

First Clinical Trial
2006
NCT00449917
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

3iNATURE | Laboratoire PILEJE | Pilege | Pileje | PiLeJe

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 3)

Diarrhea (Phase 4)

Irritable Bowel Syndrome (Phase 4)

Recurrence (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 11